Jiangsu Nhwa Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1999-03-29
- Employees
- 5.3K
- Market Cap
- -
- Website
- http://www.nhwa-group.com
A Study of NH280105 in Healthy Adult Participants
Phase 1
Not yet recruiting
- Conditions
- Alzheimer Disease
- Interventions
- Drug: NH280105- SADDrug: NH280105- MADDrug: Placebo
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06870058
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
A Phase II Study to Evaluate NH102 for Depression
Phase 2
Recruiting
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06842992
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, China
Single Ascending Dose Study of NH102 in Healthy Subjects
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT05015192
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, China
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
Phase 1
- Conditions
- Schizophrenia
- Interventions
- Drug: 18mg CY150112Drug: 24mg CY150112Drug: 0.5mg CY150112Drug: 1.5mg CY150112Drug: 4.5mg CY150112Drug: 10mg CY150112
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04839926
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients
Phase 4
Completed
- Conditions
- Efficacy and Safety of Mivacurium Chloride for Pediatric Patients
- Interventions
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1152
- Registration Number
- NCT02117401
Combined Use of Etomidate and Propofol in Painless Gastroscopy.
Phase 4
- Conditions
- Safety of Gastroscopy
- Interventions
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 2450
- Registration Number
- NCT01913054
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, China
🇨🇳General Hospital of Chinese Air Force, Peking, Beijing, China
🇨🇳Chaoyang Hospital Attached to the Capital Medical University, Peking, Beijing, China
Etomidate Emulsion for Sedation in Patients Scheduled for Upper Gastrointestinal (GI) Endoscopy
Not Applicable
Completed
- Conditions
- Complication of Gastrostomy
- Interventions
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 328
- Registration Number
- NCT01729897
© Copyright 2025. All Rights Reserved by MedPath